These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936. Tayek JA Diabetologia; 2006 Nov; 49(11):2807-8. PubMed ID: 16955252 [No Abstract] [Full Text] [Related]
4. From the World Congress of Cardiology, Barcelona, 2006--Support for wider metformin usage in type 2 diabetes. Cardiovasc J S Afr; 2006; 17(5):267. PubMed ID: 17117236 [No Abstract] [Full Text] [Related]
6. Prevention of type 2 diabetes: role of metformin. Charles MA; Eschwège E Drugs; 1999; 58 Suppl 1():71-3; discussion 75-82. PubMed ID: 10576529 [TBL] [Abstract][Full Text] [Related]
7. Is metformin more than an oral hypoglycaemic agent? Vague P Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S5-7. PubMed ID: 14502095 [No Abstract] [Full Text] [Related]
8. Is Metformin Cardioprotective? A New Piece to the Puzzle. Dixon DL; Carbone S J Cardiovasc Pharmacol; 2024 Aug; 84(2):155-157. PubMed ID: 39115717 [No Abstract] [Full Text] [Related]
11. Drugs for type 2 diabetes mellitus: the imperative for cardiovascular outcome assessment. Gore MO; McGuire DK Diab Vasc Dis Res; 2012 Apr; 9(2):85-8. PubMed ID: 22496441 [No Abstract] [Full Text] [Related]
12. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes]. Hemmingsen B; Lund SS; Vaag A Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642 [TBL] [Abstract][Full Text] [Related]
13. [Hypoglycemic therapy in heart disease patients with type 2 diabetes mellitus]. Cosmi F; Cosmi D G Ital Cardiol (Rome); 2010 Jun; 11(6):460-6. PubMed ID: 20922871 [TBL] [Abstract][Full Text] [Related]
14. After Metformin - Next Steps for Type 2 Diabetes with Low Cardiovascular Risk. Rydén L; Standl E N Engl J Med; 2022 Sep; 387(12):1136-1138. PubMed ID: 36130002 [No Abstract] [Full Text] [Related]
15. Antipsychotic drug-treated patients best suited for metformin therapy. Hasnain M; Vieweg WV Acta Psychiatr Scand; 2013 Dec; 128(6):488-9. PubMed ID: 23659558 [No Abstract] [Full Text] [Related]
16. Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials. Lamanna C; Monami M; Marchionni N; Mannucci E Diabetes Obes Metab; 2011 Mar; 13(3):221-8. PubMed ID: 21205121 [TBL] [Abstract][Full Text] [Related]
19. Metformin for schizophrenia: an editorial comment to Curtis J, Newall H, Shiers D, Samaras K. 'Considering metformin in cardiometabolic protection in psychosis'. Taylor D Acta Psychiatr Scand; 2012 Oct; 126(4):233-4. PubMed ID: 22974204 [No Abstract] [Full Text] [Related]
20. [Metformin in type 2 diabetes. An extensive observational study confirms the agent as first choice--so far]. Rydén M Lakartidningen; 2011 Jan 26-Feb 1; 108(4):136. PubMed ID: 21365817 [No Abstract] [Full Text] [Related] [Next] [New Search]